$Ocugen (OCGN.US)$ Once you do you have EUA from the FDA, what happens next?We will be able to bring an initial supply of tens of millions of doses of Covaxin from India to the United States and get them to work saving American lives. We will also move on the technology transfer process so that larger production can begin in the United States. At this point, we are aiming for 100 million doses this year. We plan to create new jobs in Pennsylvania at Ocugen and various vendors, and additional jobs across the country supporting development, manufacturing, and distribution.
...
...
$Sintx Technologies (SINT.US)$
Sintx Technologies saw a increase in short interest in the month of February. As of February 12th, there was short interest totaling 1,170,000 shares, an increase of 124.7% from the January 28th total of 520,600 shares. Based on an average daily trading volume, of 3,260,000 shares, the days-to-cover ratio is currently 0.4 days.
Sintx Technologies saw a increase in short interest in the month of February. As of February 12th, there was short interest totaling 1,170,000 shares, an increase of 124.7% from the January 28th total of 520,600 shares. Based on an average daily trading volume, of 3,260,000 shares, the days-to-cover ratio is currently 0.4 days.
1
$Tesla (TSLA.US)$
Second sight CEO attended Neuralink unveil in 2019 and then essentially confirmed collaboration: https://neurotechreports.com/pages/Neuralink-launch-collaborations.html…
Second sight CEO attended Neuralink unveil in 2019 and then essentially confirmed collaboration: https://neurotechreports.com/pages/Neuralink-launch-collaborations.html…
$Second Sight Medical Products (EYES.US)$ $EYES $TSLA nobody is seeing this... -- Second sight CEO attended Neuralink unveil in 2019 and then essentially confirmed collaboration: https://neurotechreports.com/pages/Neuralink-launch-collaborations.html…
4